Skip to main content
Clinical Trials/JPRN-jRCTs043230043
JPRN-jRCTs043230043
Recruiting
Phase 1

Efficacy and Safety of Adipose Stem Cell Culture Supernatant Extract for Skin Ulcers

akagawa Masahiro0 sites80 target enrollmentJune 23, 2023
Conditionsskin ulcer

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
skin ulcer
Sponsor
akagawa Masahiro
Enrollment
80
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 23, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
akagawa Masahiro

Eligibility Criteria

Inclusion Criteria

  • 1\. men and women between 18 and 90 years of age
  • 2\. patients with various types of skin ulcers (excluding head and face)
  • 3\. patients with skin ulcers with a maximum diameter of 1 cm or more but less than 9 cm
  • 4\. patients whose consent to participate in this study has been obtained by signing a consent form by the patient or a proxy.

Exclusion Criteria

  • 1\. patients with vasculitic ulcers
  • 2\. patients requiring inpatient treatment for ulcers
  • 3\. patients with severe anemia or thrombocytopenia
  • 4\. patients with infection at the site of ulcer and tendency to exacerbation
  • 5\. patients with malignant tumors at the ulcer site
  • 6\. patients requiring surgical procedures such as amputation or skin grafting (not including debridement)
  • 7\. patients receiving continuous oral or injectable steroid hormone therapy
  • 8\. patients with severely impaired nutritional status
  • 9\. patients undergoing dialysis or immunosuppression
  • 10\. who has a history of allergy to adipose stem cell culture supernatant extract

Outcomes

Primary Outcomes

Not specified

Similar Trials